I watched the NWR preso yesterday and I’m not convinced who the target audience was. If it were to attract new investors there was no value proposition given in real dollars terms. If the intention were to speak to existing holders, no new news was imparted on us. So it gets back to my question, who was Dr Brad speaking to? The lasting takeaway was the reality check that 2025 is the target year for the phase 2 trials so it makes me think I’m too ambitious we’ll see significant improvement to the sp in ‘24. I’d be delighted to be proven wrong on this point.
- WE.
IMU Price at posting:
10.5¢ Sentiment: Buy Disclosure: Held
(20min delay)